Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
about
Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's diseaseAlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research.A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.BACE1 as a potential biomarker for Alzheimer's diseaseOPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE.β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment.BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's diseaseCan BACE1 inhibition mitigate early axonal pathology in neurological diseases?Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and presenilin.Alzheimers disease: review of emerging treatment role for intravenous immunoglobulins.Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.Silencing of amyloid precursor protein expression using a new engineered delta ribozyme.Investigation of flap flexibility of β-secretase using molecular dynamic simulations.Tripchlorolide Attenuates β-amyloid Generation via Suppressing PPARγ-Regulated BACE1 Activity in N2a/APP695 Cells.Alzheimer's disease hypothesis and related therapies.
P2860
Q26999922-1E5E8727-3421-416C-A3BC-4A29D6DD9180Q33567120-BE9C5FC1-7442-42DA-8B67-2277E841DDA5Q34575658-3AB0286F-F0D6-41F8-A678-58DCD3E6475DQ34767547-8432FF4C-66AD-426D-B2EE-76B25E892A98Q35617556-C763EB3F-0F3C-4445-B1F4-A2318DCA4BBAQ35856328-3DA0A6AE-F218-41C2-9165-ACB31B0B3722Q36221014-7E79CAC2-61FE-48A1-AE49-DD09268A730FQ36379519-2A272D15-285F-4EF3-9336-2402ADB6E650Q37057708-42B2071E-DE5D-4825-9472-84C2CBB3A723Q37715869-9BD15FD3-3191-4C79-8463-E19DB62998F8Q37961473-BBA64FB3-36E7-4C11-ADE0-FBFE02DD9871Q38122150-2C10027A-669E-49B2-8194-6AD9A9A7C946Q39108867-195D27FF-D99F-4971-A8FF-158EA6BCEDACQ41841425-3B153560-FCE9-4D04-9DD6-3CD8C79F332AQ46812285-30F59610-4C93-4F88-A36F-8A36E62EF98BQ48451297-7C0CF523-E105-49D9-BE3F-D527FD282ACCQ49762112-FB490F2B-C5CB-475B-BC22-B08D18BF4760
P2860
Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is BACE1 a suitable therapeuti ...... ategies and future directions.
@en
Is BACE1 a suitable therapeuti ...... ategies and future directions.
@nl
type
label
Is BACE1 a suitable therapeuti ...... ategies and future directions.
@en
Is BACE1 a suitable therapeuti ...... ategies and future directions.
@nl
prefLabel
Is BACE1 a suitable therapeuti ...... ategies and future directions.
@en
Is BACE1 a suitable therapeuti ...... ategies and future directions.
@nl
P2093
P2860
P356
P1433
P1476
Is BACE1 a suitable therapeuti ...... ategies and future directions.
@en
P2093
Amos C Hung
David H Small
David W Klaver
Matthew C J Wilce
Robert Gasperini
P2860
P304
P356
10.1515/BC.2010.089
P50
P577
2010-08-01T00:00:00Z